Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00791336 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
A Phase 2 study, sponsored by University of Iowa.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00791336 is a Phase 2 study that was terminated before completion, run by University of Iowa. The registered enrollment target is 1 participants.
The verdict
NCT00791336, a Phase 2 study, was terminated before completion, sponsored by University of Iowa.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study combines nelfinavir (NFV) with radiation therapy and chemotherapy as a treatment for non-small cell lung cancer (NSCLC) who are considered candidates for pre-operative treatment.
Interventions
- DRUG Nelfinavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00791336
The ClinicalTrials.gov registry entry for NCT00791336 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nelfinavir is the first listed.
NCT00791336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00791336 about?
NCT00791336 is a clinical study titled "Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer". This study combines nelfinavir (NFV) with radiation therapy and chemotherapy as a treatment for non-small cell lung cancer (NSCLC) who are considered candidates for pre-operative treatment.
What is the current status of trial NCT00791336?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-08. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00791336?
The interventions under investigation include: Nelfinavir (DRUG).
Who is sponsoring clinical trial NCT00791336?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.